Literature DB >> 34128498

Operative Versus Nonoperative Treatment of Acute Displaced Distal Clavicle Fractures: A Multicenter Randomized Controlled Trial.

Jeremy A Hall1, Christine E Schemitsch1, Milena R Vicente1, Niloofar Dehghan2,3, Aaron Nauth1, Lauren L Nowak4, Emil H Schemitsch4, Michael D McKee2.   

Abstract

OBJECTIVES: To evaluate the differences in patient outcomes after operative or nonoperative treatment of displaced, type II distal clavicle fractures.
DESIGN: Multicenter, prospective, randomized controlled trial.
SETTING: Level I trauma centers. PATIENTS/PARTICIPANTS: Patients with completely displaced type II distal clavicle fractures were included. Fifty-seven patients were randomized: 27 to the operative group and 30 to the nonoperative group. INTERVENTION: Patients randomized to nonoperative care received a standard shoulder sling, followed by pendulum or gentle range of motion shoulder exercises at any time as directed by the attending surgeon. Patients randomized to the operative group received plate fixation with a precontoured distal clavicular plate or a "hook" plate within 28 days from injury. MAIN OUTCOME MEASURE: Disabilities of the Arm, Shoulder and Hand scores at 1 year.
RESULTS: There were no between-group differences in Disabilities of the Arm, Shoulder and Hand or Constant scores at 1 year. More patients in the operative group went on to union (95% vs. 64%, P = 0.02) within 1 year. Twelve patients in the operative group underwent a second operation for implant removal (12/27, 44%). In the nonoperative group, 6 patients (6/30, 20%) subsequently underwent 8 operative procedures.
CONCLUSION: Although this study failed to demonstrate a difference in functional outcomes between operative and nonoperative treatment of Neer type II distal clavicle fractures, nonoperative management led to more complications including a moderate rate of nonunion, which often required secondary surgery to correct, a higher rate of early dissatisfaction with shoulder appearance, and a delayed return to activities in the first 6 months. Operative management provided a safe and reliable treatment option with few complications, but often required secondary implant removal, especially with hook plate fixation. LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34128498     DOI: 10.1097/BOT.0000000000002211

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.884


  5 in total

1.  What are the long-term patient-reported and clinical outcomes after lateral clavicle fractures? A cross-sectional study of 619 patients.

Authors:  Rens A van der Linde; Svenhjalmar van Helden; Sarah Woltz; Mostafa El Moumni; Frank F A IJpma
Journal:  Eur J Trauma Emerg Surg       Date:  2022-08-04       Impact factor: 2.374

Review 2.  Different internal fixation methods for unstable distal clavicle fractures in adults: a systematic review and network meta-analysis.

Authors:  Yinglong Xu; Xiaobo Guo; Hui Peng; Hai Dai; Zonggui Huang; Jinmin Zhao
Journal:  J Orthop Surg Res       Date:  2022-01-24       Impact factor: 2.359

3.  Safe and Effective Treatment of Compromised Clavicle Fracture of the Medial and Lateral Third Using Focused Shockwaves.

Authors:  Rainer Mittermayr; Nicolas Haffner; Sebastian Eder; Jonas Flatscher; Wolfgang Schaden; Paul Slezak; Cyrill Slezak
Journal:  J Clin Med       Date:  2022-04-02       Impact factor: 4.241

4.  Comparative analysis of arthroscopic-assisted Tight-rope technique and clavicular hook plate fixation in the treatment of Neer type IIB distal clavicle fractures.

Authors:  Si Nie; Hong-Bo Li; Li Hua; Zhi-Ming Tang; Min Lan
Journal:  BMC Musculoskelet Disord       Date:  2022-08-06       Impact factor: 2.562

5.  Bipolar clavicle fractures treatment using medial and lateral double plates: A case report.

Authors:  Haiyang Xing; Changpeng Cao; Xinxiao Chen; Yang Gao; Guanning Huang; Jiajing Zhu; Gang Wang
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.